Summary
Acorda Therapeutics is a major biotechnical company founded in 1995. Their specific focus is geared towards developing and providing the best treatment possible for all central nervous system related disorders. Acorda Therapeutics offers tailored therapy programs that are aimed specifically at restoring neurological function and providing relief in conditions such as spinal cord injury, multiple sclerosis, and Spasticity.
Zanaflex was launched by Acorda Therapeutics in 1996. It is a short-acting medication for the treatment of Spasticity and should not be used on a regular basis. Zanaflex is available in tablet and capsule form.
Eligibility
National Organization for Rare Disorders provides Acorda Therapeutics patient assistance program. NORD offers an one year supply of Zanaflex at no cost to those who are eligible for the program. Eligibility is based off of the following requirements:
What´s Next?
Fill out the program enrollment form located to your right. If you don't see an enrollment form available please call Acorda Therapeutics program directly. After filling out the enrollment form please bring the form to your doctor for proper signatures and procedures. Do not forget a self stamped envelope for them to mail in your application to the program.
Other Tips
- If you have any questions please call the Acorda Therapeutics program directly.
- Fill out as much of the information on the enrollment form as possible. The more information you have pre-filled the easier the progrm is to enroll in.
- Write down the refill dates for your program and set a reminder here on PatientAssistance.com so that you don't run out of medication.
- Do not write messy on your forms as this will delay any response.
- Call and write thank you notes to AAI Pharma Inc. program. Without their help millions of people will be without medication.